ICU Medical, Inc. $ICUI Shares Bought by Pacific Capital Partners Ltd

by · The Cerbat Gem

Pacific Capital Partners Ltd increased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 19.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 62,500 shares of the medical instruments supplier’s stock after acquiring an additional 10,000 shares during the quarter. ICU Medical comprises about 8.3% of Pacific Capital Partners Ltd’s investment portfolio, making the stock its largest position. Pacific Capital Partners Ltd owned approximately 0.25% of ICU Medical worth $7,498,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the company. Moody National Bank Trust Division raised its position in shares of ICU Medical by 0.9% during the 2nd quarter. Moody National Bank Trust Division now owns 10,751 shares of the medical instruments supplier’s stock valued at $1,421,000 after acquiring an additional 93 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in shares of ICU Medical by 11.6% during the second quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after purchasing an additional 101 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in shares of ICU Medical by 4.5% in the 2nd quarter. BNP Paribas Financial Markets now owns 2,459 shares of the medical instruments supplier’s stock valued at $325,000 after buying an additional 107 shares during the period. Thrivent Financial for Lutherans grew its holdings in shares of ICU Medical by 0.6% in the 2nd quarter. Thrivent Financial for Lutherans now owns 18,098 shares of the medical instruments supplier’s stock valued at $2,392,000 after buying an additional 114 shares during the period. Finally, Maryland State Retirement & Pension System raised its stake in ICU Medical by 1.8% during the 2nd quarter. Maryland State Retirement & Pension System now owns 7,233 shares of the medical instruments supplier’s stock worth $956,000 after buying an additional 129 shares during the period. Institutional investors own 96.10% of the company’s stock.

Insider Activity at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 930 shares of the company’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $142.34, for a total transaction of $132,376.20. Following the sale, the vice president directly owned 5,456 shares of the company’s stock, valued at approximately $776,607.04. This represents a 14.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Elisha W. Finney sold 1,285 shares of the stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $140.42, for a total transaction of $180,439.70. Following the completion of the sale, the director owned 3,995 shares of the company’s stock, valued at approximately $560,977.90. This represents a 24.34% decrease in their position. The SEC filing for this sale provides additional information. 1.50% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ICUI. Wall Street Zen downgraded ICU Medical from a “buy” rating to a “hold” rating in a report on Sunday. KeyCorp boosted their price objective on ICU Medical from $173.00 to $175.00 and gave the company an “overweight” rating in a research report on Friday, November 7th. Weiss Ratings restated a “sell (d-)” rating on shares of ICU Medical in a report on Wednesday, October 8th. Finally, Piper Sandler lifted their price target on shares of ICU Medical from $153.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $175.67.

View Our Latest Research Report on ICU Medical

ICU Medical Stock Down 1.9%

Shares of ICUI stock opened at $148.28 on Wednesday. The company has a current ratio of 2.45, a quick ratio of 1.19 and a debt-to-equity ratio of 0.62. ICU Medical, Inc. has a 1 year low of $107.00 and a 1 year high of $175.51. The firm’s fifty day moving average price is $144.11 and its two-hundred day moving average price is $131.72. The firm has a market capitalization of $3.66 billion, a P/E ratio of -478.31 and a beta of 0.80.

ICU Medical (NASDAQ:ICUI – Get Free Report) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $2.03 EPS for the quarter, topping analysts’ consensus estimates of $1.43 by $0.60. The company had revenue of $533.30 million during the quarter, compared to the consensus estimate of $511.46 million. ICU Medical had a negative net margin of 0.32% and a positive return on equity of 7.71%. The company’s quarterly revenue was down 8.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.59 EPS. ICU Medical has set its FY 2025 guidance at 7.350-7.650 EPS. On average, equities analysts predict that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

ICU Medical Profile

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Recommended Stories